WeVote

Bill

Bill

SF 2049

A bill for an act relating to autologous and directed blood donations at blood banks and hospitals.

2025-2026 Regular Session Introduced by Dennis Guth

Iowa bill establishes regulatory standards for autologous and directed blood donations at healthcare facilities to ensure patient safety and clarify donation procedures.

Subcommittee: Sweeney, Trone Garriott, and Webster.
0
WeVote Research Nonpartisan
Bill Summary · SF 2049

Legislative bill overview

SF 2049 addresses policies governing autologous blood donations (where patients donate their own blood for later use) and directed blood donations (where donors specify recipients, typically family members) at Iowa blood banks and hospitals. The bill clarifies procedures, eligibility requirements, or regulatory standards for these specialized donation types within the state's healthcare system.

Why is this important

Autologous and directed donations serve specific medical purposes—autologous donations reduce transfusion risks and dependency on the general blood supply, while directed donations allow family members to provide blood for loved ones. Clear regulatory frameworks ensure patient safety, maintain blood supply quality standards, and establish liability protections for healthcare facilities managing these alternative donation pathways.

Potential points of contention

  • Safety vs. Access balance: Regulations may restrict directed donations to reduce disease transmission risks, potentially limiting family members' ability to help relatives
  • Blood supply impact: Emphasis on autologous/directed donations could theoretically reduce the volunteer donor base that supplies the general blood inventory
  • Implementation costs: New protocols and tracking systems for these specialized donations may create administrative and financial burdens on smaller hospitals and blood banks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.